Ipr Drug Patent Portfolio
Ipr owns 2 orange book drugs protected by 14 US patents Given below is the list of Ipr's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6858618 | Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia | 17 Jun, 2022 | Expired |
| US6858618 | Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia | 17 Dec, 2021 | Expired |
| US6316460 | Pharmaceutical compositions | 04 Feb, 2021 | Expired |
| US6316460 | Pharmaceutical compositions | 04 Aug, 2020 | Expired |
| US7030152 | Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease | 02 Oct, 2018 | Expired |
| US7964614 | Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease | 02 Oct, 2018 | Expired |
| US7030152 | Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease | 02 Apr, 2018 | Expired |
| US7964614 | Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease | 02 Apr, 2018 | Expired |
| USRE37314 | Pyrimidine derivatives | 08 Jul, 2016 | Expired |
| USRE37314 | Pyrimidine derivatives | 08 Jan, 2016 | Expired |
| US5466699 | Indolyl compounds for treating migraine | 14 May, 2013 | Expired |
| US5863935 | Therapeutic heterocyclic compounds | 14 May, 2013 | Expired |
| US5466699 | Indolyl compounds for treating migraine | 14 Nov, 2012 | Expired |
| US5863935 | Therapeutic heterocyclic compounds | 14 Nov, 2012 | Expired |
Latest Legal Activities on Ipr's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Ipr.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 29 Jul, 2019 | US7964614 |
|
Maintenance Fee Reminder Mailed
Critical
| 11 Feb, 2019 | US7964614 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 08 Nov, 2018 | US7220767 (Litigated) |
|
Request for Trial Denied
Critical
| 02 Feb, 2016 | US7220767 (Litigated) |
|
Request for Trial Denied
Critical
| 27 Jan, 2016 | US6750237 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 21 Jun, 2011 | US7964614 |
|
Recordation of Patent Grant Mailed
Critical
| 21 Jun, 2011 | US7964614 |
|
Issue Notification Mailed
Critical
| 01 Jun, 2011 | US7964614 |
| Dispatch to FDC | 19 May, 2011 | US7964614 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 18 May, 2011 | US7964614 |
|
Application Is Considered Ready for Issue
Critical
| 16 May, 2011 | US7964614 |
|
Response to Amendment under Rule 312
Critical
| 16 May, 2011 | US7964614 |
|
Issue Fee Payment Verified
Critical
| 22 Apr, 2011 | US7964614 |
|
Issue Fee Payment Received
Critical
| 22 Apr, 2011 | US7964614 |
| Mail Miscellaneous Communication to Applicant | 20 Apr, 2011 | US7964614 |
Ipr's Family Patents
Ipr Drug List
Given below is the complete list of Ipr's drugs and the patents protecting them.
1. Crestor
Crestor is protected by 10 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6858618
(Pediatric)
| Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
17 Jun, 2022
(2 years ago)
| Expired |
| US6858618 | Use of rosuvastatin (zd-4522) in the treatment of heterozygous familial hypercholesterolemia |
17 Dec, 2021
(3 years ago)
| Expired |
| US6316460
(Pediatric)
| Pharmaceutical compositions |
04 Feb, 2021
(3 years ago)
| Expired |
| US6316460 | Pharmaceutical compositions |
04 Aug, 2020
(4 years ago)
| Expired |
| US7030152
(Pediatric)
| Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
02 Oct, 2018
(6 years ago)
| Expired |
| US7964614
(Pediatric)
| Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
02 Oct, 2018
(6 years ago)
| Expired |
| US7030152 | Systematic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
02 Apr, 2018
(6 years ago)
| Expired |
| US7964614 | Systemic inflammatory markers as diagnostic tools in the prevention of atherosclerotic diseases and as tools to aid in the selection of agents to be used for the prevention and treatment of atherosclerotic disease |
02 Apr, 2018
(6 years ago)
| Expired |
| USRE37314
(Pediatric)
| Pyrimidine derivatives |
08 Jul, 2016
(8 years ago)
| Expired |
| USRE37314 | Pyrimidine derivatives |
08 Jan, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Crestor's drug page
2. Zomig
Zomig is protected by 4 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5466699
(Pediatric)
| Indolyl compounds for treating migraine |
14 May, 2013
(11 years ago)
| Expired |
| US5863935
(Pediatric)
| Therapeutic heterocyclic compounds |
14 May, 2013
(11 years ago)
| Expired |
| US5466699 | Indolyl compounds for treating migraine |
14 Nov, 2012
(12 years ago)
| Expired |
| US5863935 | Therapeutic heterocyclic compounds |
14 Nov, 2012
(12 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zomig's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List